Researchers from the University of North Carolina found that activity-based therapy and care reduced the use of antipsychotics in a study of 107 people with dementia. They presented their research today at the Alzheimer’s Disease International conference. “These drugs double the risk of death and treble the risk of stroke yet have little benefit,” said Dr. Anne Corbett of the Alzheimer’s society, “It is essential we bring an end to this chemical cosh now.”
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.